ZPK Announces Financial Results for Year 2004

Published: 2005-03-21 06:56:00

Updated: 2005-03-21 06:56:00

Zuellig Pharma Korea (ZPK) announced of its financial performance results for Year 2004, in which the company reported the sales of 22.9 billion won, up by 6.1% from the prior fiscal period.

From the results announced, the company's operating profit is reported at 1.1 billion won, which shows ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK